Reports Examine Variable Results and Weight Regain With GLP-1 Drugs
publishers 6articles 6first reported 24 Sep, 08:17 UTCdeveloping since 25 Sep · 2 editions
Recent reports are examining why people have markedly different experiences with GLP-1 weight-loss drugs such as Ozempic. The Times of India reported that some patients lose more than 20% of their body weight while others lose little, while BBC Science Focus considered why the drugs stop working for some people and potential ways to address that.
Other coverage focused on what happens after treatment ends. Inc. reported on research into why people regain weight after stopping GLP-1 drugs, and South Florida Hospital News highlighted a Cleveland Clinic study of patients who discontinued them in real-world settings. Pharmaphorum separately examined the maintenance phase of GLP-1 treatment, while Yahoo News UK described one patient’s experience of difficult side effects after beginning weight-loss injections.
HOW THIS STORY WAS MADE
Written from 6 articles, headlines and summaries only; 6 independent newsrooms once syndicated copies count as one; this version written 12 h after the record first saw the story; the editor kept it as written.
- Publishers
- 6
- Source articles
- 6
- Given to the writer
- 6, headlines and summaries only
- Independent newsrooms
- 6
- This version written
- 12 h after the record first saw the story
- Second model (editor)
- kept as written
- Publication gate
- passed
- Human review
- none
Written by a language model from the sources above, then checked by a second model that may only cut, attribute or correct. How it works →